Comparison of the effect of Fumaria Parviflora and Gabapentin in Treatment of Uremic Pruritus in Hemodialysis Patients: A Randomized Clinical Trial Study

Document Type : Original Article (s)

Authors

1 Specialized Medical Assistants, Department of Internal Medicine, Clinical Research Development Center of Amir-Almomenin Hospital, Arak University of Medical Sciences, Arak, Iran

2 Assistance Professor, Department of internal medicine, Clinical Research Development Center of Amir-Almomenin Hospital, Arak University of Medical Sciences, Arak, Iran

3 Assistant Professor, Department of Traditional Medicine, Clinical Research Development Center of Traditional Medicine, Arak University of Medical Sciences, Arak, Iran

4 Medical Doctor, Student Research Committee, School of Medicine, Arak University of Medical Sciences, Arak, Iran

Abstract

Background: Pruritus is a common problem in people with chronic kidney disease undergoing hemodialysis. Itching can greatly affect the quality of life. There is no widely used and agreed-upon treatment for pruritus associated with end-stage renal disease (ESRD). Fumaria parviflora L is a medicinal plant with several medicinal properties, including outstanding anti-inflammatory activity. The aim of this study was to compare the Effect of Fumaria Parviflora and Gabapentin in the Treatment of Uremic Pruritus in Hemodialysis Patients.
Methods: A total of 52 hemodialysis patients with pruritus were randomly divided into two groups receiving Fumaria Parviflora or gabapentin. One group was given 1500 mg of Fumaria Parviflora once a day for two months and the second group was given gabapentin 300 mg three times a week after dialysis for two months. Patients' pruritus scores were assessed before and after the intervention in two groups.
Findings: This study showed that pruritus in the two groups before the intervention was not significantly different. Both gabapentin and Fumaria Parviflora significantly reduced pruritus in hemodialysis patients after the intervention. There was no significant difference between the two groups in the severity of pruritus after
the intervention.
Conclusion: The results of this study showed that both gabapentin and Fumaria Parviflora significantly reduced the rate of pruritus in hemodialysis patients. The results of this study showed that Fumaria Parviflora as a safe herbal medicine was as effective as gabapentin in reducing pruritus in uremic patients.

Keywords

References

  1. Pakfetrat M, Basiri F, Malekmakan L, Roozbeh J. Effects of turmeric on uremic pruritus in end stage renal disease patients: a double-blind randomized clinical trial. J Nephrol 2014; 27(2): 203-7.
  2. Pisoni RL, Wikström B, Elder SJ, Akizawa T, Asano Y, Keen ML, et al. Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006; 21(12): 3495-505.
  3. Kuypers DRJ. Skin problems in chronic kidney disease. Nat Clin Pract Nephrol 2009; 5(3): 157-70.
  4. Kimmel M, Alscher DM, Dunst R, Braun N, Machleidt C, Kiefer T, et al. The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 2006; 21(3): 749-55.
  5. Mettang T, Pauli-Magnus C, Alscher DM. Uraemic pruritus--new perspectives and insights from recent trials. Nephrol Dial Transplant 2002; 17(9): 1558-63.
  6. Kuypers DR, Claes K, Evenepoel P, Maes B, Vanrenterghem Y. A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant 2004; 19(7): 1895-901.
  7. Inui S. Nalfurafine hydrochloride to treat pruritus: a review. Clin Cosmet Investig Dermatol 2015; 8: 249-55.
  8. Heydari M, Dalfardi B, Hashempur MH, Kolouri S. Johannitius (809-873AD), a bridge between Greek and Persian knowledge of the pulse. Int J Cardiol 2016; 206: 112-3.
  9. Akrami R, Hashempur MH, Tavakoli A, Nimrouzi M, Sayadi M, Roodaki M, et al. Effects of Fumaria parviflora L on uremic pruritus in hemodialysis patients: a randomized, double-blind, placebo-controlled trial. Jundishapur Journal of Natural Pharmaceutical Products 2017; 12(3 Suppl): e39744.
  10. Bouya S, Balouchi A, Rafiemanesh H, Hesaraki M. Prevalence of chronic kidney disease in iranian general population: a meta-analysis and systematic review. Ther Apher Dial 2018; 22(6): 594-9.
  11. Balaskas E, Szepietowski JC, Bessis D, Ioannides D, Ponticelli C, Ghienne C, et al. Randomized, double-blind study with glycerol and paraffin in uremic xerosis. Clin J Am Soc Nephrol 2011 ;6(4): 748-52.
  12. Cheng AY, Wong LS. Uremic pruritus: from
    diagnosis to treatment. Diagnostics (Basel) 2022;12(5): 1108.
  13. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383(6603): 787-93.
  14. de Jong R, Bezemer AC, Zomerdijk TP, van de Pouw‐Kraan T, Ottenhoff TH, Nibbering PH. Selective stimulation of T helper 2 cytokine responses by the anti‐psoriasis agent monomethylfumarate. Eur J Immunol 1996; 26(9): 2067-74.
  15. Fallahzadeh MK, Roozbeh J, Geramizadeh B, Namazi MR. Interleukin-2 serum levels are elevated in patients with uremic pruritus: a novel finding with practical implications. Nephrol Dial Transplant 2011; 26(10): 3338-44.
  16. Šilhavý J, Zídek V, Mlejnek P, Landa V, Simakova M, Strnad H, et al. Fumaric acid esters can block pro-inflammatory actions of human CRP and ameliorate metabolic disturbances in transgenic spontaneously hypertensive rats. PLoS One 2014; 9(7): e101906.
  17. Litjens NH, Rademaker M, Ravensbergen B, Rea D, van der Plas MJ, Thio B, et al. Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses. Eur J Immunol 2004; 34(2): 565-75.
  18. Jazani AM, Nasimi Doost Azgomi R, Shirbeigi L. Pruritus treatment in viewpoints of traditional Persian Medicine. Iran J Med Sci 2016; 41(3 Suppl): S53.
  19. Virga G, Visentin I, La Milia V, Bonadonna A. Inflammation and pruritus in haemodialysis patients. Nephrol Dial Transplant 2002; 17(12): 2164-9.
  20. Zhou FM, Cheng RX, Wang S, Huang Y, Gao YJ, Zhou Y, et al. Antioxidants attenuate acute and chronic itch: peripheral and central mechanisms of oxidative stress in pruritus. Neurosci Bull 2017; 33(4): 423-35.
  21. Jamshidzadeh A, Niknahad H, Fereidouni F. Hepatoprotective effects of fumaria parvijlora lam. Against ccl4 toxicity on freshly isolated rat hepatocytes [in Persian]. Iranian J Basic Med Sci 2005; 8(2): 86-92.
  22. Madani H, Taleb Alhosseini M, Asgary S, Mahzouni P, Razban E. Preventive effect of hydroalcoholic extract of silybum marianum and fumaria vaillantii in atherosclerosis [in Persian]. Pharm Sci 2007; 12(4): 29-34.
Journal of Isfahan Medical School
Volume 40, Issue 697
1st Week,, February
January and February 2023
Pages 966-971

Files

Share

How to cite

Statistics